- Report this post
3/12/2024- In today's briefing we review Covid, Flu, RSV & hMPV updates, Covid & the Lungs and “Turbo cancer.”The People's Health Briefing aims to empower you with our best knowledge and thinking every Tuesday morning. Please submit your questions or any feedback you might have in the comments, by direct message, or by email to admin@rootsclinic.orgWatch now on YouTube: https://lnkd.in/gnUJnUhd#rootsempowers #communityhealth #bayarea #publichealth #Oakland #COVID19 #cdc #maskup #covidisnotover #COVIDIsAirborne #NoMoreCovidDeaths #vaccines #booster #pandemic #omicron #XBB #KeepMasksinHealthcare #LongCovid #EG.5 #wastewater #BA.2.86 #monovalent #monovalentbooster #Novavax #Pertussis #JN.1
https://www.youtube.com/
1
To view or add a comment, sign in
More Relevant Posts
-
ADACYTE THERAPEUTICS
684 followers
- Report this post
This #elearning #webinar with European leading experts in #Immunology and #IBD management, will discuss if it is possible a promise of better long-term outcomes compared with current approaches and which could be the role of #Adacolumn in that scenario.🔗
5
Like CommentTo view or add a comment, sign in
-
ACIR
3,997 followers
- Report this post
Vaccination with neoantigens naturally recognized by both CD4+ and CD8+ T cells synergized with anti-PD-1, mediating both prophylactic and therapeutic protection from SCC VII tumors in mice. Read our summary here => https://bit.ly/3Zn25JH #cancervaccine
91
2 Comments
Like CommentTo view or add a comment, sign in
-
Greg Slabodkin
- Report this post
Study reveals previously unknown properties of #immunecells that are relevant regarding both #autoimmunediseases and fighting #fungalinfections. bit.ly/3WJCXux #Tcells #cytokines #immunity #immunesystem #inflammation
1
Like CommentTo view or add a comment, sign in
-
STEMCELL Technologies
93,180 followers
- Report this post
We had a great time at the SFI-DGFI joint conference last month!If you missed our presentation on learning about how our tools can support your immune cell culture workflow, we have good news: you can access it on-demand now! ✨🖥️#immunology
15
Like CommentTo view or add a comment, sign in
-
RenMab
129 followers
- Report this post
Immunization of our target KO fully human antibody RenMice(RenMab or RenLite®) yields antibodies that target both non-hom*ologous as well as conserved regions. This approach increases the likelihood of identifying antibodies that specifically target conserved hom*ologous regions. Check out the examples below demonstrating the increased yield from RenLite® HiTS mice that bind targets from multiple species (human & monkey or human & mouse): https://renmab.com/#antibodydiscovery #antibodytherapeutics #innovation #preclinicalresearch #immunotherapy #cancerresearch #cancertherapy
Like CommentTo view or add a comment, sign in
-
Antibody Analytics
6,705 followers
- Report this post
👉 Join us for the fourth episode of SPR Reflections: https://bit.ly/3R07OkJ In today's video, our Study Manager, Dr. Louis Julien talks about how reproducible our results are here at Antibody Analytics.Let us know in the comments if you’d like a topic to be covered in our short video series. #SPRreflections #ScienceSeries #immunology #CRO #assaydevelopment #drugdiscovery #surfaceplasmonresonance
29
Like CommentTo view or add a comment, sign in
-
Biocytogen
5,704 followers
- Report this post
Immunization of our target KO fully human antibody RenMice (RenMab or RenLite®) yields antibodies that target both non-hom*ologous as well as conserved regions. This approach increases the likelihood of identifying antibodies that specifically target conserved hom*ologous regions. Check out the examples below demonstrating the increased yield from RenLite® HiTS mice that bind targets from multiple species (human & monkey or human & mouse): https://renmab.com/#antibodydiscovery #antibodytherapeutics #innovation #preclinicalresearch #immunotherapy #cancerresearch #cancertherapy
3
Like CommentTo view or add a comment, sign in
-
Zelle Biotechnology Pvt. Ltd.
9,739 followers
- Report this post
Why CST’s CAR-T?The following explanation will give a broad idea of how CST's CAR-T portfolio gives an edge over other CAR detection reagents.𝘾𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙬𝙞𝙩𝙝 𝙤𝙩𝙝𝙚𝙧 𝘾𝘼𝙍 𝘿𝙚𝙩𝙚𝙘𝙩𝙞𝙤𝙣 𝙍𝙚𝙖𝙜𝙚𝙣𝙩𝙨:•Lack of versatility•Non-specific𝘼𝙙𝙫𝙖𝙣𝙩𝙖𝙜𝙚𝙨 𝙤𝙛 𝘾𝙎𝙏 𝘼𝙣𝙩𝙞-𝘾𝘼𝙍 𝙡𝙞𝙣𝙠𝙚𝙧 𝙖𝙣𝙩𝙞𝙗𝙤𝙙𝙞𝙚𝙨:•Designed to recognize a broad range of scFv-based CARs•Specifically detect either GAS Linker or Whitlow Linker•Compatible with multi-parametric flow panels•Facilitate the monitoring of CAR expression, trafficking and persistence•Lot reservations and bulk orders available.To know more contact us oninquiry@zellebiotech.com.#zellebiotechnology#immunotherapy#cancerresearch#CARTcell#cartcelltherapy#antibody#immunology#cellsignaling
16
Like CommentTo view or add a comment, sign in
-
Mohammad Kamyari
Upperclassman Student at University of Isfahan
- Report this post
Fascinating new research 🧬 unveils how our immune system develops long-term #vaccine immunity! 💪A study in Cell Reports tracked people's B cell responses to the mRNA #COVID19 vaccine over 6 months.They found coordinated trajectories from early plasmablasts to activated and resting memory B cells. 📈 Resting B cells dominated by month 6.The spike-specific B cells showed accumulating mutations and #convergence, suggesting common pathways of #immunologicalmemory. 🤯Key hashtags: #SARSCoV2 #mRNAvaccine #systemsimmunology #Bcells #singlecellRead more: [ https://lnkd.in/eEZXSwXm ]
3
Like CommentTo view or add a comment, sign in
-
Alex Graham
Creative Writer
- Report this post
if you read the entire article, you'll see that the same scientific technology used for covid vaccine is being used to fight other life-threatening disease including types of cancer. another point for Biden, moving forward rather than backward.
Like CommentTo view or add a comment, sign in
2,550 followers
View Profile
Follow